Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
140 studies found for:    IPF | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Investigating Significant Health Trends in Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
2 Recruiting Pennsylvania Idiopathic Pulmonary Fibrosis Research Registry
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
3 Not yet recruiting CleanUP IPF for the Pulmonary Trials Cooperative
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Antimicrobial therapy: Co-trimoxazole or Doxycycline;   Other: No Intervention: Standard of Care
4 Recruiting Autoantibody Reduction Therapy in Patients With Idiopathic Pulmonary Fibrosis
Condition: Ambulatory IPF
Interventions: Drug: Rituximab;   Drug: Placebo
5 Recruiting Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
6 Not yet recruiting Yoga Effect on Quality of Life Study Among Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Other: Yoga
7 Recruiting High Oxygen Delivery to Preserve Exercise Capacity in Idiopathic Pulmonary Fibrosis Patients Treated With Nintedanib
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Other: 60% Oxygen;   Other: Standard of Care
8 Recruiting Safety and Tolerability Study in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Conditions: Idiopathic Pulmonary Fibrosis;   IPF
Interventions: Drug: tipelukast;   Drug: Placebo
9 Recruiting Home-Based Pulmonary Rehab for Patients With Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Behavioral: Physical exercise training;   Behavioral: Cognitive exercise training
10 Recruiting Targeting Pro-Inflammatory Cells in Idiopathic Pulmonary Fibrosis: a Human Trial
Condition: Idiopathic Pulmonary Fibrosis (IPF)
Intervention: Drug: Dasatinib + Quercetin
11 Recruiting Biomarker Discovery for Novel Drug Development in Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis (IPF)
Intervention:
12 Not yet recruiting A Pilot Trial of Herpesvirus Treatment in Idiopathic Pulmonary Fibrosis (IPF)
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Valganciclovir;   Drug: Placebo
13 Recruiting PaTH Clinical Data Research Network (CDRN) Idiopathic Pulmonary Fibrosis (IPF) Clinician Patient Partnership Cohort
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
14 Recruiting Quality of Life Study in Participants With IPF Under Pirfenidone Treatment
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: Pirfenidone
15 Recruiting All-Case Surveillance of Ofev in Patients With IPF in Japan
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: Nintedanib
16 Recruiting Pilot Trial Of Omeprazole in Idiopathic Pulmonary Fibrosis (IPF)
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Omeprazole;   Drug: Matched placebo
17 Recruiting Short-term Effects of Supplemental Oxygen in Patients With IPF
Condition: Idiopathic Pulmonary Fibrosis (IPF)
Interventions: Other: Medical air;   Other: Oxygen (2Liter/min);   Other: Oxygen (4Liter/min)
18 Recruiting Validation of the Risk Stratification Score in Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
19 Recruiting Study to Evaluate the Effect of GBT440 Administered to Subjects With IPF on Supplemental Oxygen at Rest
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: GBT440
20 Recruiting IPF Italian Observational Study (FIBRONET) in Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.